Answers are grounded in this paper and cite their sources.
Shows Ligustilide activates cGAS-STING in mice to prevent lung tumorigenesis, suggesting a novel chemoprevention method.
Lung cancer is a malignant tumor of the bronchial mucosa or glands, with the fastest increasing incidence and mortality rates. In this study, we elucidated for the mechanism of prevention of tobacco-specific nitrosamine (NNK)-induced lung carcinogenesis by Ligustilide (LIG), an active ingredient of traditional Chinese medicine (TCM), through activation of the cGAS-STING innate immune pathway. In the NNK-treated A/J mouse model, LIG (10/40 mg/kg) intervention significantly ameliorated lung histopathological injury, restored body weight, and down-regulated pro-inflammatory factor IL-6 and IL-1β expression. Mechanistic studies showed that LIG reversed NNK-induced inhibition of cGAS-STING pathway protein expression, promoted STING phosphorylation (p-STING), induced type I interferon production by initiating the TBK1-IRF3/NF-κB signaling axis, which induces type I interferon production and recruits alveolar CD8 + T cells, and synergistically activates the DNA damage response by elevating ROS levels and maintaining homeostasis. In vitro experiments further supporting LIG directly combines with STING and activates the cGAS-STING pathway and attenuates NNK damage in lung epithelial cells (MLE-12). This study has suggests that LIG provides a novel naturally derived strategy for lung cancer chemoprevention by targeting STING proteins and re-establishing the immunosurveillance microenvironment.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: